Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by K.B. Sonawane
Serious Adverse Drug Events Reported to the Food and Drug Administration (FDA): Analysis of the FDA Adverse Event Reporting System (FAERS) 2006-2011 Database
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Adverse Events Associated With Colchicine Drug Interactions: Analysis of the Public Version of the Fda Adverse Event Reporting System
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Texas Pharmacists’ Knowledge of Reporting Serious Adverse Drug Events to the Food and Drug Administration
Journal of the American Pharmacists Association : JAPhA
Pharmacology
Pharmacy
Spontaneous Reporting on Adverse Events by Consumers in the United States: An Analysis of the Food and Drug Administration Adverse Event Reporting System Database
Drugs - Real World Outcomes
Pharmacology
Adverse Events Associated With Pediatric Use of Proton Pump Inhibitors: Analysis of the Fda Adverse Event Reporting System
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Bisphosphonates and Nonhealing Femoral Fractures: Analysis of the FDA Adverse Event Reporting System (FAERS) and International Safety Efforts
Journal of Bone and Joint Surgery - Series A
Medicine
Surgery
Orthopedics
Sports Medicine
Sports Science
Association Between Myocarditis and Other Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitor Use: Analysis of the FDA Adverse Events Reporting System (FAERS)
Journal of Cardiac Failure
Cardiovascular Medicine
Cardiology
Prm79 - Weber Effect: An Extended Analysis for Ten Years of Reporting Trends in Fda Adverse Event Reporting System (Faers)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Clustering Therapeutic Drugs Using FDA Adverse Event Reporting System
Proceedings for Annual Meeting of The Japanese Pharmacological Society
Food and Drug Administration (FDA) Postmarket Reported Side Effects and Adverse Events Associated With Pulmonary Hypertension Therapy in Pediatric Patients
Pediatric Cardiology
Child Health
Pediatrics
Cardiovascular Medicine
Perinatology
Cardiology